9:22 AM ET
8-K
Business Update
Glucotrack Business Update
Glucotrack CEO Erik Emerson provided a strategic update following the company's recent business combination with Lōkahi Therapeutics. The update highlights the development of LT-100 for osteoarthritis knee pain, including the submission of a clinical protocol for regulatory review and plans for a study evaluating subcutaneous injection efficacy.